Search
for
Sort by
Research 451–480 of 1000+
- Comparison of quality of life in patients with androgenetic alopecia and alopecia areata
- Comparative efficacy and safety of systemic steroids, oral JAK inhibitors and Contact Immunotherapy in the Treatment of severe alopecia areata: a systematic review and network meta-analysis
- A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata
- Pattern hair loss distribution: a novel presentation for alopecia areata
- Combination Treatment with Methotrexate for Severe Alopecia Areata
- CTLA4 +49AG (rs231775) and CT60 (rs3087243) gene variants are not associated with alopecia areata in a Mexican population from Monterrey Mexico
- Effects of platelet-rich plasma application on hair follicle count, telogen/anagen ratio, and miniaturized hair ratio in patients with androgenic alopecia: alone or in combination with other treatments
- Localized corticosteroid delivery in alopecia areata using microneedle patch technology
- Immunohistochemical assessment of SOX10 and its relation to the immune cellular infiltrate in alopecia areata follicles
- Elevated serum heat shock protein-70 and interleukin-15: prognostic biomarkers correlating with clinical severity and diagnostic efficacy in active alopecia areata
- Ocular comorbidities and its relation to clinical and dermoscopic features in patients with alopecia areata: a case-control study
- Assessment of miR-19b-3p, miR-182-5p, and miR-155-5p expression and its relationship with alopecia areata severity
- Fractional carbon dioxide laser alone and as an assisted drug delivery for treatment of alopecia areata: a clinical, dermoscopic and immunohistochemical study
- Peripheral neuropathy associated with tofacitinib use in alopecia universalis
- Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata
- Serum granulysin as a possible key marker of the activity of alopecia areata
- Clinical Trial Eligibility in Real‐World Alopecia Areata Patients Treated With Baricitinib
- Evaluation of the efficacy of topical metformin 10% and 20% versus topical potent steroid in the treatment of patients with alopecia areata
- Patient-reported outcome improvements following scalp hair regrowth among patients with Alopecia Areata: analysis of the ALLEGRO-2b/3 trial
- Progressive alopecia areata during TNF-α inhibition with intralesional corticosteroid failure and subsequent improvement following JAK1 inhibition
- Treatments for alopecia areata: A systematic review and network meta‐analysis
- The Pathogenesis of Oxidative Stress in Androgenetic Alopecia
- Evaluation of the Efficacy and Safety of Oral Tofacitinib for the Treatment of Alopecia Areata in Children
- Real-world evidence in alopecia areata treatment: A narrative review
- Excimer Light versus Combination of Tacrolimus and Excimer Light in the Treatment of Alopecia Areata
- Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata
- The Impact of Growth Factors in Platelet‐Rich Plasma Combination Therapy for Androgenic Alopecia
- Successful treatment of severe diffuse alopecia areata with abrocitinib
- Differential diagnosis of posterior scalp hair loss
- Serum levels of interleukin-1 (IL-1α, IL-1β) in patients with alopecia areata